Nutriband Inc.

NASDAQ:NTRB

Biotechnology

Healthcare
$4.82 +22.32%

+$0.85 today

Market cap
$58.59M
Beta
1.97
P/E (TTM)
-1.8
EPS (TTM)
-$0.66
52W Low $2.80High $8.63

Volume 0.03M

Average 0.01M

NTRB Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

Nutriband Inc.NASDAQ: NTRB

Retained Earnings · Q1 FY2026 · quarter ended Apr 2026

Retained earnings remains negative

Q1 FY2026 retained earnings was -$47.93M, compared with -$39.85M a year earlier.

Context

  • Retained earnings amounted to 695.5% of total assets at the end of Q1 FY2026, up 47.7 pp from a year earlier.
  • Retained earnings grew in size in 3 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether retained earnings keeps falling in the next quarterly balance sheet after a -20.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterApr 2026
-$47.93M-2.7% QoQ
Last fiscal yearJan 2026
-$46.69M-21.4% YoY
Year agoApr 2025
-$39.85M-20.3% since
Retained Earnings past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-20.3%——
1 year-21.4%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Retained Earnings history

USD · from the balance sheet

Latest · FY2025
(46.69M) USD
Year-over-year change
-21.4%

Retained Earnings vs competitors

How NTRB compares with its peers on the latest reported figures

  • NTRB's Apr 2026 retained earnings of -$47.93M is the highest of the 9 companies compared; the peer median is -$431.16M.
  • Its year-over-year change of -20.3% is the 4th highest of 9, against a peer median of -22.7%.
  • Retained earnings amounts to 695.5% of total assets for NTRB, versus a peer median of 288.7%.
NTRB Competitors Peer median
Retained Earnings for NTRB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
NTRBNutriband Inc.Apr 2026-$47.93M -20.3%—695.5%
GANXGain Therapeutics, Inc.Mar 2026-$106.96M -24.8%—570.8%
XBITXBiotech Inc.Mar 2026-$141.88M -39.5%—101.5%
ACRVAcrivon Therapeutics, Inc. Common StockMar 2026-$293.92M -35.7%—272.6%
ADAGAdagene Inc.Dec 2025-$328.79M -5.7%—420.1%
TCRXTScan Therapeutics, Inc.Mar 2026-$533.53M -30.4%—264.1%
FBIOFortress Biotech, Inc.Mar 2026-$623.68M +17.0%—174.8%
ACETAdicet Bio, Inc.Mar 2026-$634.94M -20.7%—374.9%
RLMDRelmada Therapeutics, Inc.Mar 2026-$717.32M -8.9%—304.8%
Peer median (excluding NTRB) -$431.16M-22.7%—288.7%

Competitors are the stored peer set for NTRB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Jan 2022
FY2022
Jan 2023
FY2023
Jan 2024
FY2024
Jan 2025
FY2025
Jan 2026
Cash & Equivalents4.89M1.99M492.94K4.31M4.57M
Short-term Investments00000
Net Receivables71.38K113.05K148.65K73.85K118.4K
Inventory131.65K229.34K168.61K212.04K117.99K
Other Current Assets000(546)0
Total Current Assets5.47M2.69M1.02M4.79M4.99M
Property, Plant & Equipment (Net)998.34K960.49K806.3K695.06K639.26K
Goodwill5.35M5.02M5.02M1.72M1.72M
Intangible Assets926.91K780.43K667.28K261.09K200.43K
Long-term Investments00000
Tax Assets00000
Other Non-current Assets000(63)0
Total Non-current Assets7.27M6.76M6.5M2.68M2.56M
Total Assets12.74M9.46M7.52M7.47M7.55M
Account Payables00680.13K698.82K502.65K
Short-term Debt14.12K19.74K127.18K128.14K161.32K
Tax Payables00000
Deferred Revenue106.27K162.9K157.5K155.88K120.3K
Other Current Liabilities639.54K534.68K000
Total Current Liabilities779.26K748.61K999.09K982.85K784.28K
Long-term Debt101.12K100.5K79.83K58.21K35.86K
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities101.12K134.77K79.83K58.21K84.17K
Total Liabilities880.38K883.39K1.08M1.04M868.45K
Common Stock9.16K7.83K8.86K11.08K12.16K
Retained Earnings(18.01M)(22.49M)(27.98M)(38.46M)(46.69M)
Accumulated OCI(304)(304)(304)(304)(304)
Other Stockholders Equity00000
Minority Interest00000
Total Equity11.86M8.57M6.44M6.43M6.68M
Total Debt134.57K185.81K241.29K186.35K245.49K
Net Debt(4.76M)(1.8M)(251.66K)(4.13M)(4.33M)

Nutriband Inc.

NASDAQ:NTRB

Intrinsic Alpha fair value

Locked

Current Price

$4.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.